Spokane, WA, United States
Spokane, WA, United States

Avista Utilities is a U.S. energy company. Avista generates and transmits electricity and distributes natural gas, while providing energy solutions for residential, commercial, and industrial customers. Approximately 1,550 employees provides electricity, natural gas, and other energy services to 359,000 electric and 320,000 natural gas customers in three western states. The service territory covers 30,000 square miles in eastern Washington, northern Idaho, and parts of southern and eastern Oregon, with a population of 1.5 million.Avista Utilities is the regulated business unit of Avista Corp., an investor-owned corporation headquartered in Spokane, Washington. Avista Corp.'s primary, non-utility subsidiary was Ecova, an energy and sustainability management company with over 700 expense management customers, representing more than 600,000 sites. In 2014 Ecova was sold to Cofely, a subsidiary of GDF Suez.The company was founded in 1889 as Washington Water Power Company, until 1998 when the board of directors approved a name change to Avista Utilities. At that time, the company also bought naming rights for Spokane's minor league baseball park, Avista Stadium. Wikipedia.


Time filter

Source Type

News Article | April 19, 2017
Site: www.labdesignnews.com

NewsFacility and technology upgrades will enable Avista Pharma Solutions to deliver additional microbiology, sterility testing and microbial ID service offerings. Contributed Author: Laboratory Design NewsletterTopics: New Projects


— The “Continuous Glucose Monitoring Systems Market - Medical Devices Pipeline Assessment, 2017” the report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Continuous Glucose Monitoring Systems pipeline products. Browse the 157 Tables and Figures, 70 Companies, Spread across 268 Pages Report Available at http://www.reportsnreports.com/contacts/discount.aspx?name=958615. Scope of the Report: Extensive coverage of the Continuous Glucose Monitoring Systems under development The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities The report reviews the major players involved in the development of Continuous Glucose Monitoring Systems and list all their pipeline projects The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage The report provides key clinical trial data of ongoing trials specific to pipeline products Recent developments in the segment / industry Companies are mentioned: A. Menarini Diagnostics S.r.l., Abbott Diabetes Care, Inc., Advanced Biosensors-Ohio, Llc, Advanced Medical Electronics Corporation, Arkal Medical, Inc., Bio-Impedance General Ltd., Biorasis, Inc., Biovotion AG, CALISTO MEDICAL, INC. (Inactive), Cardiff University Company, City, University of London, Columbia University, ConvaTec Group Plc, Cyber Medical Ltd., Debiotech SA, DexCom Inc, DirectSens GmbH, Echo Therapeutics Inc, Ecole Polytechnique Federale de Lausanne, eLutions Integrated, EyeSense GmbH, Flowsion A/S, Gili Medical Ltd, Globe Medical Tech Inc, and Others. Place Order to This Report at http://www.reportsnreports.com/purchase.aspx?name=958615. Continuous Glucose Monitoring Systems Market- Recent Developments : Mar 30, 2017: ConvaTec Expands Unomedical Manufacturing Technology Partnership with Medtronic Diabetes to Meet Growing Demand Mar 29, 2017: ConvaTec Group: Directorate changes Mar 28, 2017: Novo Acquires 19.95% Stake in Convatec from Nordic Capital and Avista for USD1.22 Billion Mar 28, 2017: ConvaTec: Proposed Directorate Changes Mar 27, 2017: Integrity Applications Board Appoints John Graham CEO and Chairman, Angela Strand Vice Chairman Mar 24, 2017: Medicare Announces Criteria Covering Dexcom G5 Mobile CGM for All People with Diabetes on Intensive Insulin Therapy Mar 21, 2017: Medtronic Prices Public Offering of 1.7% Notes Due 2019 for USD1 Billion Mar 21, 2017: Medtronic Prices Public Offering of 3.35% Notes Due 2027 for USD850 Million Mar 21, 2017: Medtronic Prices Public Offering of 4.625% Notes Due 2045 for USD150 Million Mar 21, 2017: Tenax Therapeutics Announces Year-End 2016 Financial Results and Provides Corporate Update Mar 14, 2017: PositiveID’s E-N-G Mobile Systems’ 2017 Bookings Through February Total $1.7 Million, Up More than 200% from Prior Quarter Mar 13, 2017: DexCom Appoints Richard Collins to Board of Directors Mar 08, 2017: Tandem Diabetes Care Reports 2016 Financial Results Continuous Glucose Monitoring Systems Market- Recent Developments for 2017, January and February is also mentioned. List of Tables Table 1: Continuous Glucose Monitoring Systems - Pipeline Products by Stage of Development Table 2: Continuous Glucose Monitoring Systems - Pipeline Products by Segment Table 3: Continuous Glucose Monitoring Systems - Pipeline Products by Territory Table 4: Continuous Glucose Monitoring Systems - Pipeline Products by Regulatory Path Table 5: Continuous Glucose Monitoring Systems - Pipeline Products by Estimated Approval Date And more List of Figures Figure 1: Continuous Glucose Monitoring Systems - Pipeline Products by Stage of Development Figure 2: Continuous Glucose Monitoring Systems - Pipeline Products by Territory Figure 3: Continuous Glucose Monitoring Systems - Pipeline Products by Regulatory Path Figure 4: Continuous Glucose Monitoring Systems - Pipeline Products by Estimated Approval Date Figure 5: Continuous Glucose Monitoring Systems - Ongoing Clinical Trials Complete Table of Content is Available at Continuous Glucose Monitoring Systems - Medical Devices Pipeline Assessment, 2017. About Us: ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports. For more information, please visit http://www.reportsnreports.com/reports/958615-continuous-glucose-monitoring-systems-medical-devices-pipeline-assessment-2017.html


News Article | April 20, 2017
Site: www.gizmag.com

Taking a break from the everyday hatchbacks and crossovers that populate its production lineup, MG Motor is dreaming bigger with its latest concept car. Unveiled at Auto Shanghai, the MG E-motion is a voluptuously sultry sports coupe with powerful electric drive. And this concept might just preview a return to the sportiness of MG's past. As attractive as it is, the E-motion feels like a book we've read before. There's the eye roll of a name, which has already been used in some form by Volkswagen and Fisker Inc., styling that's sexy but quite similar to some other recent concept cars, and generic industry standards like 311+ miles (500+ km) of range, sub-four-second 0-62 mph (100 km/h) acceleration, and an "intelligent infotainment system" for the youngsters. We don't expect a trio of different doors, but an innovative detail or two wouldn't hurt. All that said, it's a book we don't mind reading again, especially when it's penned by an author with as much sports car history as the MG marque, history we'd love to see repeated. Styling-wise, the E-motion reminds us very much of the 2015 Mazda RX-Vision and 2016 Buick Avista. A set of butterfly doors give it a little extra auto show flash, and the headlights take inspiration from the London Eye ferris wheel. MG hasn't provided details on the powertrain it envisions motivating the E-motion, leaving those 311-mile and sub-four-second predictions as orphans without parents. Whatever the exact layout and spec, MG says the greater modular electric platform was developed in house. More interesting than any of the limited information MG has officially detailed, Autocar reports that the E-motion could go into production by 2020, with a base price under £30,000 (approx. US$38K). For now, it's on display at Auto Shanghai.


Patent
Avista | Date: 2017-04-03

The invention relates to 1,2,4-thiadiazole derivatives and their use to treat parasites.


Patent
Avista | Date: 2016-07-15

The present invention relates to isothiazoline compounds of formula (I). The compounds are useful for combating or controlling invertebrate pests, in particular arthropod pests and nematodes. The invention also relates to a method for controlling invertebrate pests by using these compounds and to veterinary compositions comprising said compounds.


Patent
Avista | Date: 2015-09-01

Liquid fuels are routinely used to provide energy for many different uses. Transferring and distributing liquid fuels have many challenges including providing safe and reliable transfers and distributions. Liquid fuels, for example, Liquid Natural Gas (LNG) may be transferred from a vessel at a relatively low flow rate. This system allows for leaks to be captured and contained to an area of a water based transfer platform rather than allowing the spill to spread out on the surface of the water.


Patent
Avista | Date: 2011-02-08

Techniques and systems are described that assist in predicting, diagnosing, and/or managing an incident in a utility service area. A communication system is provided in the service area to communicate with nodes of the service area. Nodes of the service area may communicate with the communication system using a variety of different communication technologies and/or communication protocols. In some instances, nodes of the communication are capable of two-way communication with the communication system.


Patent
Avista | Date: 2011-02-08

Techniques and systems are described that assist in predicting, diagnosing, and/or managing an incident in a utility service area. A communication system is provided in the service area to communicate with nodes of the service area. Nodes of the service area may communicate with the communication system using a variety of different communication technologies and/or communication protocols. In some instances, the communication system may detect a communication technology and/or a communication protocol used by a node.


Operation of a hydropower generation facility may be optimized by consideration and analysis of multiple factors influencing function of the facility. Aspects of the facility and surrounding hydraulic system are represented in a model that may include efficiency curves for hydropower turbines. Efficiency curves for one or more turbines are approximated by piecewise linear functions. The use of piecewise linear representations allows for calculation of recommended operational settings as well as predicted outputs in real time. An optimization system may consider input data such as weather and market prices for electricity. The input data may also include desired operational outputs of the hydropower generation facility. A user interface may present recommendations for specific operational settings to achieve the desired operational outputs.


Patent
Avista | Date: 2016-01-14

The present invention relates to isothiazoline compounds of formula (I). The compounds are useful for combating or controlling invertebrate pests, in particular arthropod pests and nematodes. The invention also relates to a method for controlling invertebrate pests by using these compounds and to veterinary compositions comprising said compounds.

Loading Avista collaborators
Loading Avista collaborators